FOS and malignant colon neoplasm: Additionally, IL-1β activates miR-146a, which in turn targets p38, ERK, and JNK MAP kinases, along with downstream transcription factors GATA2, c-Fos, and c-Jun, that are implicated in metastatic progression in colon cancer cells [75].